BioLife Sciences Inc. (BLFE)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 16, 2025, 4:00 PM EDT
BioLife Sciences Market Cap
BioLife Sciences has a market cap or net worth of $4.83 thousand as of July 17, 2025. Its market cap has decreased by -99.45% in one year.
Market Cap
4.83K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 15, 2020, BioLife Sciences's market cap has decreased from 89.39M to 4.83K, a decrease of -99.99%. That is a compound annual growth rate of -86.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 4.83K | - |
| Dec 31, 2024 | 4.83K | -99.33% |
| Dec 29, 2023 | 724.41K | -84.62% |
| Dec 30, 2022 | 4.71M | -94.56% |
| Dec 31, 2021 | 86.56M | 249.03% |
| Dec 31, 2020 | 24.80M | -72.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.59B |
| Veradigm | 857.64M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.00M |
| Glass House Brands | 456.35M |
| CytoDyn | 399.02M |
| Northwest Biotherapeutics | 386.53M |